AT
Ascend Therapeutics
VA - Herndon
Pharmaceutical3 H-1B visas (FY2023)Focus: Specialty pharmaceuticals, women's health
Ascend Therapeutics is a life sciences company focused on Specialty pharmaceuticals, women's health.
Women's Health
Employees
1001-5000
Open Jobs
0
Products & Portfolio (4)
ELUXADOLINE
eluxadoline
Pre-Launch
ORAL · TABLET
mu-opioid receptor agonist; eluxadoline is also a delta opioid receptor antagonist and a kappa opioid receptor agonist. The binding affinities (Ki) of eluxadoline for the human mu and delta opioid receptors are 1.8 nM and 430 nM, respectively. The binding affinity (Ki) of eluxadoline for the human kappa opioid receptor has not been determined; however, the Ki for guinea pig cerebellum kappa opioid receptor is 55 nM. In animals, eluxadoline interacts with opioid receptors in the gut.
ESTROGEL
estradiol
LOE Approaching
TRANSDERMAL · GEL, METERED
Estrogen Receptor Agonists
2004
30
SKYTROFA
lonapegsomatropin-tcgd
Peak
INJECTION · INJECTABLE
2021
30
YORVIPATH
palopegteriparatide
Growth
PeptideSUBCUTANEOUS · SOLUTION
2024
0
Pipeline & Clinical Trials
Acteev™ Masks
SARS CoV-2 InfectionClinical Trials (1)
NCT05036941A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)
N/Acerebral embolic protection
Transcatheter Aortic Valve Implantation (TAVI)Clinical Trials (1)
NCT06962371Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
N/AThe Mycophenolate Pregnancy Registry
Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune DiseasesFace-and-Neck Cream
Skin Aging of Face and NeckClinical Trials (1)
NCT07403942The Skin Anti-Aging Effects of Vitamin K2 (MK-7): a Clinical Split-Face/Neck Trial
N/AQuality IQ Patient Simulations
PainClinical Trials (1)
NCT04080037Assessing Opioid Care Practices Using CPV Patient Simulation Modules
N/APaclitaxel Poliglumex
Advanced Colorectal CancerClinical Trials (1)
NCT00598247A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
Phase 1ASN-002
Basal Cell Nevus SyndromeClinical Trials (1)
NCT02550678A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT03208296Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)
Phase 1/2Dihydrotestosterone
HealthyClinical Trials (1)
NCT00490022Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]
Phase 1/2Afimoxifene
Cyclic Breast Pain, Cyclic MastalgiaClinical Trials (1)
NCT00272714Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women
Phase 2Dihydrotestosterone
HypogonadismClinical Trials (1)
NCT00163566Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
Phase 2ASN-002
Basal Cell CarcinomaClinical Trials (1)
NCT04416516Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor
Phase 2Estrogel
Postmenopausal SymptomsClinical Trials (1)
NCT00160173Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2023
Portfolio: 4 approved products, 12 clinical trials
Top TAs: Endocrinology, Women's Health
H-1B (2023): 3 approvals
Portfolio Health
Pre-Launch1 (25%)
Growth1 (25%)
Peak1 (25%)
LOE Approaching1 (25%)
4 total products
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
3
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub